top of page

Edelblum Lab

 IBD research laboratory at Rutgers studying immune/epithelial interactions to better understand the underlying causes of Crohn's disease and discover potential new areas for therapeutic development

  • LinkedIn - White Circle
  • Twitter - White Circle


3.1 million Americans


Crohn's disease and ulcerative colitis affect 1.3% of the population with 70,000 new cases diagnosed every year. IBD is caused by a combination of genetic and environmental factors that lead to an abnormal immune reaction to the normal bacteria found in the intestine.



Sinai graphic 1.png

The Edelblum Lab is excited to be joining the Department of Pathology at Icahn School of Medicine at Mount Sinai in March 2023! We will be recruiting new staff to join our team at all levels to expand our basic/translational studies on IELs in IBD. Please contact us if you are interested in joining our team!

AJP CellPhys rev Fig 2.tif

Weili Xu, PhD provides an insightful summary of why we need to examine the functional significance of CD103 signaling in the IEL compartment

August 2022

AFong head temp.tif

Welcome to the Edelblum Lab, Andrew!

Andrew joins the lab as research technician after working on Shigella with Dr. Christina Faherty at Harvard/Mass General 

August 2022


Karen chats with the hosts of Immunology Podcast about gamma delta T cells, IBD and immunology-themed cakes!

August 2022

GFX video.gif

New publication on the role of specific microbiota in promoting gamma delta IEL proliferation and migration.

Click here to read our recently published work in Mucosal Immunology 

May 2022



Success! Message received.

  • White Twitter Icon
  • LinkedIn - White Circle
bottom of page